The association of carotid intima media thickness with retinol binding protein-4 and total and high molecular weight adiponectin in type 2 diabetic patients

Journal of Diabetes and Metabolic Disorders

Volumn 11, Issue 1, 2012, Pages 1-7

  Mansouri, Masoumeh ^a   Heshmat, Ramin ^a   Tabatabaei Malazy, Ozra ^a   Sharifi, Farshad ^a   Badamchizadeh, Zohreh ^a   Alatab, Sudabeh ^a   Omidfar, Kobra ^a   Fakhrzadeh, Hossein ^a   Larijani, Bagher ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adipokines; B mode ultrasonography; Carotid intima media thickness; Enzyme linked immunosorbant assay (ELISA); Type 2 diabetes

Indexed keywords

ADIPONECTIN; RETINOL BINDING PROTEIN 4; HIGH MOLECULAR WEIGHT ADIPONECTIN; TOTAL ADIPONECTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADIPOCYTOKINE;

ADULT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; BLOOD PRESSURE; BODY MASS; CARDIOMETABOLIC RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; PROTEIN BLOOD LEVEL; RISK FACTOR; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; DISEASE ASSOCIATION; HUMAN TISSUE; PREDICTION;

EID: 84867200537     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-11-2     Document Type: Article

References (41)

1. Wacker FJ, Yaung LH, Inzucchi SH, et al: Detection of silent myocardial Ischemia in asymptomatic diabetic subjects. Diabetes Care 2004, 27: 1954-1961.
2. Stehouwer CD, Henry RM, Ferreria I: Arterial stiffness in diabetes and the metabolic syndrome a pathway to cardiovascular disease. Diabetologia 2008, 51:527-539.
3. Thanh HT, Benzaquen BS: Screening for subclinical coronary artery disease measuring carotid intima media thickness. Am J Cardio 2009, 104:1383-1388.
4. Djaberi R, Schuijf JD, Jukema JW, et al: Increased carotid intima-media thickness as a predictor of the presence and extent of abnormal myocardial perfusion in type 2 diabetes. Diabetes Care 2010, 33(2):372-374.
5. Esteve E, Ricart W, Fernandez-Real JM, Adipocytokines and insulin resistance. The possible role of lipocalin-2, retinol binding protein-4, and insulin resistance: Adipocytokines and insulin resistance. The possible role of lipocalin-2, retinol binding protein-4, and insulin resistance. Diabetes Care 2009, 32(Supplement 2):S362-S367.
6. Rabe K, Lehrke M, Parhofer KG, et al: Adipocytokines and insulin resistance. Mol Med 2008, 14(11-12):741-751.
7. Rasouli N, Kern PA: Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008, 93(11):564-573.
8. Beauloye V, Zech F, Mong HTT, et al: Determinants of early Atherosclerosis in obese children and adolescents. J Clin Endocrinol Metab 2007, 92(8):3025-3032.
9. Hutley L, Prins B: Fat as endocrine organ: relationship to the metabolic Syndrome. Am J Med Sci 2005, 330:280-289.
10. Hassink S, Balagopal PB: RBP4: from retinol transporter to biomarker. J Pediatr 2009, 154:5-7.
11. Graham TE, Yang Q, Blüher M, et al: Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006, 354:2552-2563.
12. Balagopal P, Graham TE, Kahn BB, et al: Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007, 92(5):1971-1974.
13. Maghbooli Z, Hossein-Nezhad A, Mirzaei K, et al: Association between retinol-binding protein 4 concentrations and gestational diabetes mellitus and risk of developing metabolic syndrome after pregnancy. Reprod Sci 2010, 17(2):196-201.
14. Shimada K, Miyazaki T, Daida H: Adiponectin and atherosclerotic disease. Clin Chim Acta 2004, 344:1-12.
15. Hotta K, Funahashi T, Arita Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler ThrombVasc Bio 2000, l20:1595-1599. 159.
16. Mansouri M, Keshtkar A, Hasani-Ranjbar S, et al: The impact of one session resistance exercise on Plasm adiponectin and RBP4 concentration in trained and untrained healthy young men. Endocrin J 2011, 58(10):861-868.
17. Greenland p, Abrams J, Aurigemma GP: Prevention conference: beyond secondary prevention: Identifying the high-risk patient for primary prevention: non invasive tests of atherosclerotic burden. Circulation 2000, 101:E16-E22.
18. Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
19. Shin JB, Seong YJ, Lee HJ, et al: Foot Screening Technique in a Diabetic Population. J Korean Med Sci 2000, 15:78-82.
20. Szmitko PE, Teoh H, Stewart DJ, et al: Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol 2007, 292:1655-1663.
21. Lo J, Dolan SE, Kanter JR, et al: Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women. J Clin Endocrinol Metab 2006, 91:1677-1682.
22. Pilz S, Horejsi R, Moller R, et al: Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005, 90:4792-4796.
23. Iglseder B, Mackevics V, Stadlmayer A, Tasch G, Ladurner G, Paulweber B: Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery Atherosclerosis. Stroke 2005, 36:2577-2582.
24. Mangge H, Almer G, Haj-Yahya S, et al: Pre atherosclerosis and adiponectin subfractions in obese adolescents. Obesity 2008, 16(12):2578-2584.
25. Norata GD, Raseli S, Grigore L, et al: Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 2007, 38:2844.
26. Nilsson PM, Engström G, Hedblad B, et al: Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance. Arterioscler Thromb Vasc Biol 2006, 26:2758-2762.
27. Ingelsson E, Lind L: Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the. elderly. Diabetes Care 2009, 32:733-735.
28. Takebayashi K, Suetsugu M, Wakabayashi S, et al: Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007, 92:2712-2719.
29. Park SE, Kim DH, Lee JH, et al: Retinol-binding protein-4 is associated with endothelial dysfunction in adults with newly diagnosed type 2 diabetes mellitus. Atherosclerosis 2009, 204:23-25.
30. Behrendt D, Gans p: Endothelial function. from vascular biology to clinical applications. Am J Cardiol 2002, 90:40L-48L.
31. Crous J: Predictive value of carotid 2-dimensionalultrasound. Am J Cardiol 2001, 88:27-30.
32. Wang Z, Nakayama T: Inflammation, a Link between Obesity and Cardiovascular Disease. Mediat Inflamm 2010, 2010:535918.
33. Szmitko PE, Wang CH, Weisel RD, et al: New markers of inflammation and endothelial cell activation. Circulation 2003, 108:1917-1923.
34. Verma S, Anderson TJ: Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002, 105:546-549.
35. Chen H, Montagnani M, Funahashi T, et al: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003, 278:45021-45026.
36. Iglseder B, Mackevics V, Stadlmayer A, et al: Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis. Stroke 2005, 36:2577-2582.
37. Steinberg HO, Chaker H, Leaming R, et al: Obesity/insulin resistance is associated with endothelial dysfunction implication for the syndrome of insulin resistance. J Clin Invest 1996, 97:2601-2610.
38. Kobashi C, Urakaze M, Kishida M, et al: Adiponectin inhibits endothelial synthesis of interleukin-8. Circ Res 2005, 97:1245-1252.
39. Ouchi N, Kihara S, Arita Y, et al: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
40. Kuboki K, Jiang ZY, Takahara N, et al: Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000, 101:676-681.
41. Peppa-P M, Scordili M, Antoniou A, et al: Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care 1998, 21(6):1004-1007.